UK biotech and University of Birmingham in licensing deal for nasal spray targeting COVID-19 09-Nov-2021 By Jane Byrne Birmingham Biotech and the University of Birmingham have signed a licensing agreement for an anti-viral nasal spray against COVID-19.
Amgen v Sanofi ruling: It is time to kiss goodbye to broad, functional patent claims for antibodies 25-Mar-2021 By Jane Byrne A US court’s recent decision to find in favor of Sanofi and invalidate Amgen's broad antibody patent claims has biotech manufacturers concerned about how to preserve their IP.